If you need more lookups,
subscriptions start at $34 USD/month.
Chris Sugg Location
California, United States
Chris Sugg Work
Executive Director, Healthcare Market of Florida and Puerto Rico @ (January 2022 - Present)
Hematology Market Access Business Partner -Special Assignment @ (June 2025 - September 2025)
Executive Director, Medical Affairs @ (January 2020 - December 2021)
Sr. Director, Clincal Value and Outcomes @ (November 2017 - January 2020)
Senior Director, Clinical Value and Outcomes @ (July 2016 - November 2017)
Senior Director and Head, Field Medical, Managed Markets @ (October 2013 - May 2016)
National Director, National Accounts-Oncology Managed Markets @ (April 2011 - October 2013)
Oncology Global Scientific Affairs @ (January 2010 - April 2011)
Global Lead, New Product Strategy, Market Access and Medicines Futures @ (October 2008 - January 2010)
Director, Emerging Markets and Asia Pacific Scientific Medical Affairs @ (April 2008 - October 2008)
Senior Regional Medical Scientist, Medical Affairs and Managed Markets @ (January 2002 - April 2008)
Senior Pharmaceutical Sales Representative @ (January 2000 - January 2002)
Senior Healthcare Representative @ (May 1999 - January 2001)
Chris Sugg Education
University of Florida
Master's degree (Applied Pharmacoeconomics, Health Outcomes & Health Policy)
2012-2015
The University of North Carolina at Chapel Hill
PharmD (Doctor of Pharmacy)
1993-1999
Harvard University
Fellow (Albert Schweitzer )
1998-1999
Chris Sugg Summary
Chris Sugg, based in California, United States, is currently a Executive Director, Healthcare Market of Florida and Puerto Rico at Genentech. Chris Sugg brings experience from previous roles at Genentech, Pharmacyclics, an AbbVie Company and Seattle Genetics. Chris Sugg holds a 2012 - 2015 Master's degree in Applied Pharmacoeconomics, Health Outcomes & Health Policy @ University of Florida. Chris Sugg has 4 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Chris Sugg?
Find contact details for 700 million professionals.